Strike action between Monday 2 October to Thursday 5 October 2023

Consultants and junior doctors at The Christie will both strike between 7am on Monday 2 October to 7am on Thursday 5 October 2023. Both consultants and junior doctors will still provide emergency care during their strikes.

We are proactively contacting patients with appointments that may be affected by this strike. If you have an appointment at the Trust on any of these dates, please continue to come to The Christie and our other centres as planned unless we contact you to tell you otherwise. There may be longer waits than usual in clinics during this time.

Please do not call to check if your appointment is still going ahead.

Skip to Content

Clinical trials in Hodgkin lymphoma

The list below shows The Lymphoma Group's current clinical trials open for recruitment for Hodgkin lymphoma patients.

  • ANIMATE - A phase II study testing a targeted drug called nivolumab

    Suitable for patients with lymphoma which has come back after previous treatment

  • AVENuE - A phase II trial of avelumab for untreated advanced classical Hodgkin lymphoma.

    Suitable for patients with classical Hodgkin lymphoma who have not yet received treatment

With special thanks to the following:

Lymphoma actionCRUKBloodwiseNCRI

Last updated: February 2023